LEONARDO PIMENTAL MARCAL to Protein Kinase Inhibitors
This is a "connection" page, showing publications LEONARDO PIMENTAL MARCAL has written about Protein Kinase Inhibitors.
Connection Strength
0.019
-
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial. Lancet Oncol. 2024 May; 25(5):649-657.
Score: 0.019
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.